The Annual Alpha-1 Conference for 2017 will take place on Friday October 20th in Marino Institute of Education on Griffith Avenue in Dublin 9. We are delighted to announce this year’s special guest speaker is the President and CEO of the US Alpha-1 Foundation Henry Moehring. Other speakers include Dr. Aisling de Paor from DCU School of Law who will discuss genetic discrimination in Ireland and Professor Gerry McElvaney who will highlight new and emerging therapies for Alpha-1.
If you would like to attend please let us know by calling 01-8093871 or email alpha1@rcsi.ie.
Full Agenda
09.30 Registration, Tea and Coffee
10.00 Conference Opening by Henry Moehring, CEO and President, US Alpha-1 Foundation
10.10 Alpha-1 – The US Experience
Henry Moehring, CEO and President, US Alpha-1 Foundation
10.40 New Therapies for Alpha-1
Professor Gerry McElvaney, Respiratory Consultant, Beaumont Hospital
11.10 Coffee Break
11.30 Genetic Discrimination in Ireland
Dr. Aisling de Paor, Lecturer in School of Law & Government, Dublin City University
12.00 National AATD Targeted Detection Programme & National AATD Registry: An Update
Dr. Tomás Carroll & Margaret Molloy, Alpha One Foundation
12.30 Research Projects in Alpha-1
Dr. Emer Reeves, Noreen Lacey, Danielle Dunlea, Laura Fee, RCSI
13.00 Light Lunch Provided in College Cafeteria
14.00The SZ Question – An Irish Family Study
Dr. Alessandro Franciosi, Clinical Lecturer and Researcher, RCSI
Eóin Durkan, PhD Student, School of Health and Human Performance, Dublin City University
15.00 Closing Remarks
Info Centre
WhatisAlpha-1Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
WhatisAlpha-1AntitrypsinDeficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
HowDoIGetTested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie
Save the Date – Alpha-1 Conference 2017
The Annual Alpha-1 Conference for 2017 will take place on Friday October 20th in Marino Institute of Education on Griffith Avenue in Dublin 9. We are delighted to announce this year’s special guest speaker is the President and CEO of the US Alpha-1 Foundation Henry Moehring. Other speakers include Dr. Aisling de Paor from DCU School of Law who will discuss genetic discrimination in Ireland and Professor Gerry McElvaney who will highlight new and emerging therapies for Alpha-1.
If you would like to attend please let us know by calling 01-8093871 or email alpha1@rcsi.ie.
Full Agenda
09.30 Registration, Tea and Coffee
10.00 Conference Opening by Henry Moehring, CEO and President, US Alpha-1 Foundation
10.10 Alpha-1 – The US Experience
Henry Moehring, CEO and President, US Alpha-1 Foundation
10.40 New Therapies for Alpha-1
Professor Gerry McElvaney, Respiratory Consultant, Beaumont Hospital
11.10 Coffee Break
11.30 Genetic Discrimination in Ireland
Dr. Aisling de Paor, Lecturer in School of Law & Government, Dublin City University
12.00 National AATD Targeted Detection Programme & National AATD Registry: An Update
Dr. Tomás Carroll & Margaret Molloy, Alpha One Foundation
12.30 Research Projects in Alpha-1
Dr. Emer Reeves, Noreen Lacey, Danielle Dunlea, Laura Fee, RCSI
13.00 Light Lunch Provided in College Cafeteria
14.00 The SZ Question – An Irish Family Study
Dr. Alessandro Franciosi, Clinical Lecturer and Researcher, RCSI
14.30 Pulmonary Rehabilitation & Exercise Demonstration
Eóin Durkan, PhD Student, School of Health and Human Performance, Dublin City University
15.00 Closing Remarks
Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie